8-K: My Size Secures $2.5M Private Placement

My Size, Inc. announced a $2.5 million private placement of common stock or pre-funded warrants, along with Series C and D warrants, to fund general corporate purposes.

Summary

• My Size, Inc. has entered into definitive agreements for a private placement to raise approximately $2.5 million in gross proceeds.
• The offering involves the sale of unregistered pre-funded warrants, Series C warrants, and Series D warrants.
• The purchase price is $1.91 per share or pre-funded warrant, with associated warrants included.
• Pre-funded warrants are exercisable at $0.001 per share and do not expire.
• Series C warrants have a five-year term and Series D warrants have an 18-month term from the effective date of a resale registration statement.
• The company intends to use the net proceeds for general corporate purposes, including working capital.
• H.C. Wainwright & Co. is acting as the exclusive placement agent for the offering.
• The offering is expected to close on or about September 16, 2026.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive development, indicating the company is securing necessary capital through a private placement, but the terms and potential dilution warrant careful consideration.

Positives

• Secures approximately $2.5 million in gross proceeds, providing capital for general corporate purposes and working capital.
• The private placement is priced at-the-market under Nasdaq rules, suggesting alignment with current trading valuations.
• Inclusion of pre-funded warrants offers immediate exercisability with a nominal exercise price.
• H.C. Wainwright & Co., a reputable placement agent, is facilitating the transaction.

Negatives

• The offering involves unregistered securities, requiring a resale registration statement, which may lead to delays or complications.
• Potential for dilution to existing shareholders due to the issuance of new warrants and shares.
• The company faces obligations to pay liquidated damages if registration statement deadlines are missed.
• The company agreed not to effect variable rate transactions for 12 months post-Effective Date, potentially limiting future financing flexibility.

Risks

• Failure to file or maintain the effectiveness of the resale registration statement could result in liquidated damages.
• The company's ability to successfully integrate potential defense technology acquisitions is uncertain.
• Risks associated with expanding into the defense technology sector, including limited operating experience and regulatory hurdles.
• The company's liquidity and ongoing capital requirements remain a concern.
• Potential for dilution to existing shareholders from the issuance of warrants and underlying shares.
• The company must maintain compliance with Nasdaq listing requirements.

Future Outlook

The company intends to use the net proceeds for general corporate purposes, including working capital. The offering is expected to close on or about September 16, 2026, subject to customary closing conditions. The company is also pursuing a strategy to expand into defense technology through selective acquisitions.

Management Comments

• My Size, Inc. (NASDAQ: MYSZ) (MySize or the Company), a global provider of AI-driven retail technology solutions, today announced that it has entered into definitive agreements for the issuance and sale of 1,308,901 of its shares of common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.91 per share (or pre-funded warrant) in a private placement priced at-the-market under Nasdaq rules.
• The aggregate gross proceeds to the Company from the offering are expected to be approximately $2.5 million.
• My Size currently intends to use the net proceeds from the offering for general corporate purposes, including working capital.

Industry Context

StockSavvy.ai notes that My Size is operating in the AI-driven retail technology sector and is also exploring expansion into defense technology. This capital raise is crucial for its ongoing operations and strategic initiatives, including potential acquisitions in the defense sector.

Stakeholder Impact

• Shareholders may experience dilution in their ownership percentage due to the issuance of new warrants and potential shares.
• Existing shareholders' voting power may be diluted.
• The capital infusion could support the company's operations and strategic growth, potentially benefiting long-term shareholder value.
• Creditors may see an improvement in the company's financial stability due to the capital raise.

Next Steps

• The offering is expected to close on or about September 16, 2026.
• The company is required to file a resale registration statement with the SEC within 15 days of the signing date (September 15, 2026).
• The registration statement must be declared effective within 45 days (or 75 days if reviewed by the SEC) after the signing date.
• The company intends to use the net proceeds for general corporate purposes, including working capital.
• The company is pursuing a strategy to expand into defense technology through selective acquisitions.

Key Dates

Recommendation

The capital raise provides necessary funding but comes with potential dilution and registration requirements. The company's strategic expansion into defense technology introduces new risks and opportunities. A 'hold' recommendation is appropriate pending further clarity on the integration of new ventures and the successful execution of the capital raise and registration process.

Keywords

private placement, warrants, securities purchase agreement, registration rights, H.C. Wainwright & Co., capital raise, common stock, pre-funded warrants